CLASS II Drug recall · Reported 12 Dec 2012 · FDA Enforcement Report

Thyro-Tab 0.088 mg recalled by Lloyd Inc. of Iowa

Lloyd Inc. of Iowa is recalling Thyro-Tab 0.088 mg, distributed nationwide in the US. The recall was initiated on 9 Jul 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #HA31411 and #HE17811
Quantity recalled3,826,269 tablets

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-076-2013
FDA event ID
62511
Recalling firm
Lloyd Inc. of Iowa, Shenandoah, IA
Classification
Class II
Status
Terminated
Recall initiated
9 Jul 2012
FDA classified
3 Dec 2012
Reported
12 Dec 2012
Type
Voluntary: Firm initiated
Customers notified by
Telephone

Timeline

9 Jul 2012Recall initiated by company
3 Dec 2012Classified by FDA+147 days
12 Dec 2012Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

cGMP Deviations; does not meet in process specification requirements

Product as listed by the FDA

Thyro-Tab 0.088 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

Where it was distributed

Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

cGMP Deviations; does not meet in process specification requirements

Which lots are affected?

Lot #HA31411 and #HE17811

Where was it sold?

Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

11 other products · FDA event 62511

This product is part of a recall event; the main page for the event is Levothroid (levothyroxine sodium tablets, USP), 112 mcg recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IILevothroid (levothyroxine sodium tablets, USP), 112 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IILevothroid (levothyroxine sodium tablets, USP), 137 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IIThyro-Tab 0.137 mg recalled by Lloyd Inc. of IowaLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IILevothroid (levothyroxine sodium tablets, USP),125 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IILevothroid (levothyroxine sodium tablets, USP), 88 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IIThyro-Tab 0.050 mg recalled by Lloyd Inc. of IowaLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IILevothroid (levothyroxine sodium tablets, USP), 300 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IIThyro-Tab 0.112 mg recalled by Lloyd Inc. of IowaLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IILevothroid (levothyroxine sodium tablets, USP), 50 mcg recalledLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IIThyro-Tab 0.125 mg recalled by Lloyd Inc. of IowaLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide
CLASS IIThyro-Tab 0.300 mg recalled by Lloyd Inc. of IowaLloyd Inc. of IowaManufacturing (CGMP) DeviationsNationwide

More recalls from Lloyd Inc. of Iowa

All 36

Other Thyro-tab recalls

All 10